Dimethyldithiophosphate

Dimethyldithiophosphate (DMDTP) is a urinary metabolite of organophosphate pesticides commonly used in agriculture and pest control. 

DMDTP levels are a biomarker of recent exposure. They reflect pesticide absorption through ingestion, inhalation, or skin contact, helping assess potential health risks associated with organophosphate exposure.

What is Dimethyldithiophosphate (DMDTP)?

Dimethyldithiophosphate (DMDTP) is a urinary metabolite of organophosphate (OP) insecticides commonly used in agriculture. It is a biomarker of recent OP pesticide exposure, reflecting total body burden from ingestion, inhalation, or dermal absorption. 

However, due to environmental degradation, low-level DMDTP may be detected even without direct pesticide contact.

DMDTP belongs to the dialkyl phosphate (DAP) metabolite group, which indicates OP exposure but does not specify the exact pesticide source. When analyzed alongside other DAPs, DMDTP helps assess population exposure trends and potential health risks.

Relationship to Cholinesterase Inhibition

Organophosphate pesticides work by inhibiting acetylcholinesterase, an enzyme essential for nerve function. While DMDTP does not directly measure cholinesterase inhibition, its presence confirms exposure to pesticides that can impair neurological function.

Clinical Relevance of DMDTP Testing

DMDTP testing is not a routine clinical assessment but is valuable in specific contexts where organophosphate pesticide exposure is a concern.

Occupational Monitoring: Individuals who work in agriculture, pesticide manufacturing, or pest control are at higher risk of organophosphate exposure, making DMDTP testing useful for biomonitoring in these populations.

Environmental and Accidental Exposure Assessment: In cases of pesticide spills, contamination, or suspected exposure, DMDTP testing can help determine recent contact with dimethyl organophosphate pesticides.

Epidemiological Studies: Researchers use DMDTP testing in population-based studies to assess trends in organophosphate exposure and its potential health effects. 

Data from the U.S. National Health and Nutrition Examination Survey (NHANES) found that children from agricultural communities had higher DMDTP levels, highlighting their increased vulnerability to pesticide exposure.

However, while OP metabolites were detected in meconium, DMDTP was absent, suggesting limited utility as a long-term marker.

Test Procedure and Interpretation

DMDTP is a urinary metabolite of some organophosphate pesticides; urinary samples are required for assessment.

DMDTP is quantified using isotope-dilution gas chromatography–tandem mass spectrometry (GC–MS/MS), ensuring high sensitivity.

Clinical Significance of High Levels of DMDTP

Elevated DMDTP levels (>0.1 µg/L) indicate recent exposure to dimethyl organophosphate pesticides such as azinphos-methyl, and phosmet. The higher the level, the greater the exposure, though DMDTP alone is not a direct measurement of cholinesterase inhibition.

Potential Health Implications

Acute organophosphate toxicity can present with:

• Neuromuscular symptoms – Muscle weakness, tremors, and twitching
• Cholinergic crisis (SLUDGE syndrome) – Salivation, Lacrimation, Urination, Defecation, Gastrointestinal distress, Emesis
• Respiratory compromise – Bronchospasm, excessive secretions, respiratory depression
• Severe toxicity – Seizures, coma, and death

Research links elevated OP metabolites (including DMDTP) to higher depression risk, particularly in men and younger adults.

Clinical Significance of Low Levels of DMDTP

Low or undetectable DMDTP levels generally indicate minimal or no recent significant exposure to dimethyl OP pesticides. However, low-level, chronic exposure remains a research focus, with some studies linking persistent OP exposure to neurological dysfunction.

Order Toxin Testing

Click here to compare testing options and order testing to assess toxin levels.